Substituent Effects of Heptamethine Cyanine Dyes on Drug Uptake in Patient‐Derived Glioma Cells
Carina J Dumo, Peter J Choi, Yuge Liu, Osaid Muhammad, Jason A Correia, Mike Dragunow, Thomas I‐H Park, Jiney Jose · 2026
Read Substituent Effects of Heptamethine Cyanine Dyes on Drug Uptake in Patient‐Derived Glioma Cells by Carina J Dumo, Peter J Choi, Yuge Liu, Osaid Muhammad, Jason A Correia, Mike Dragunow, Thomas I‐H Park, Jiney Jose (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13549794.txt.
Description
Carina J Dumo and co-authors hitch a brain cancer drug to glowing dye molecules that cross into the brain, and test whether small chemical decorations change the ride. Glioblastoma hides behind the blood-brain barrier and varies wildly between patients. The team attached crizotinib, a kinase blocker, to heptamethine cyanine dyes bearing different functional groups, then tried the conjugates on tumor cells grown from four patients.
The constructs entered the glioma cells, and the uptake helps explain why the conjugates hit harder than the plain drug in these dish tests. Swapping the dye's decorations shifted behavior, giving chemists a dial to tune. The authors frame the work as proof of concept: a barrier-crossing carrier plus a known drug, tailored one substituent at a time.
Catalog record
| CREATOR | Carina J Dumo, Peter J Choi, Yuge Liu, Osaid Muhammad, Jason A Correia, Mike Dragunow, Thomas I‐H Park, Jiney Jose |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 23 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |